Plant-based
Scalable
Cellular blueprint
Medical breakthrough
Pre-clinical studies have demonstrated locomotor recovery in small-animal models. CelluBridge™ has been recognized by the U.S. Food and Drug Administration with a Breakthrough Device designation. The initial target for Spiderwort Biotechnologies’ research is acute, complete thoracic spinal cord injury repair.
Scaffolding for life
CelluBridge™ is being developed to work with the body’s own cells, providing a framework for the functional growth and regeneration of neurons.
Natural solution
CelluBridge™ is a cellulose-based biomaterial that intends to provide a natural scaffold for tissue growth.
*Spiderwort Biotechnologies medical devices are under development and not commercially available.